专题:Heparin-Induced Thrombocytopenia and Thrombosis

This cluster of papers focuses on the phenomenon of Heparin-Induced Thrombocytopenia (HIT) and its associated thrombotic complications, particularly in the context of vaccination. The papers cover various aspects including pathogenesis, diagnosis, management, immune response, and the role of anticoagulation therapy in HIT. Additionally, they explore the clinical features and outcomes related to HIT and thrombosis.
最新文献
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

article Full Text OpenAlex

Cellular and Humoral Response to Sars-Cov-2 Vaccine Bnt162b2 in Adults with Chronic Kidney Disease G4/5

preprint Full Text OpenAlex

High Incidence of In-Hospital Venous Thromboembolism Early After Lung Transplantation Despite Thromboprophylaxis

article Full Text OpenAlex

COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems

article Full Text OpenAlex

Antibody Response before and after the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients

article Full Text OpenAlex

Cryoglobulinemic vasculitis and membranoproliferative glomerulonephritis in a patient with cured virus C infection

article Full Text OpenAlex

Antiphospholipid antibody syndrome complicating infective endocarditis – case report

article Full Text OpenAlex

The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review

review Full Text OpenAlex

E078 Long term outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: a single centre study

article Full Text OpenAlex

Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments

preprint Full Text OpenAlex

近5年高被引文献
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

article Full Text OpenAlex 2213 FWCI528.10549474

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

article Full Text OpenAlex 1471 FWCI353.68066595

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

article Full Text OpenAlex 976 FWCI235.4480925

Avacopan for the Treatment of ANCA-Associated Vasculitis

article Full Text OpenAlex 842 FWCI114.61386044

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

letter Full Text OpenAlex 729 FWCI51.42002187

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

article Full Text OpenAlex 652 FWCI42.64277774

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

article Full Text OpenAlex 614 FWCI40.81418521

Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

article Full Text OpenAlex 574 FWCI131.20001699

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

article Full Text OpenAlex 536 FWCI129.6744354

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

letter Full Text OpenAlex 510 FWCI123.57210902